Bluetongue Vaccine Release Outlines Strength of Intervet/SPAH Combination
NETHERLANDS - Intervet/Schering-Plough Animal Health has released the first batch of Bovilis BTV8 vaccine against bluetongue to supply in Northern Europe.

Intervet Has Developed Bluetongue Vaccine
THE NETHERLANDS – Animal health company Intervet International bv, part of Schering-Plough Corporation, has developed a vaccine against Bluetongue serotype 8, for sheep and cattle. The vaccine has been taken into production now. Intervet is aiming to...

Intervet bought by Schering-Plough
NETHERLANDS - American based company Schering-Plough has announced it is to acquire the Dutch veterinary company Intervet as part of its buy out of Organon BioSciences, the pharmaceutical division of chemical company Akzo Nobel.